U.S. Contraceptives Drugs And Devices Market

U.S. Contraceptives Drugs And Devices Market Size, Share, Growth, Outlook, and Opportunity
Analysis, 2018-2026
Contraceptives are birth spacing products that aid in avoiding unplanned pregnancy. There are five
widely used contraceptive methods, namely sterilization, hormonal method, barrier method,
emergency contraception, and intrauterine method. Sterilization is the most common method
implemented globally. While there are a plethora of female contraceptives available in the market,
companies and a few University researchers are trying to introduce male contraceptive methods.
Women contraceptive methods include vaginal rings, diaphragms, female condoms, oral pills, and
intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side
effects. The use of contraceptives can avoid 60% of maternal deaths and 57% of child deaths
worldwide, as opined by the World Health Organization (WHO) in 2014. Therefore, various family
planning initiatives have been introduced by governmental and non-governmental agencies in order
to create awareness about prevention of unplanned pregnancy.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/368
Companies present in the contraceptives market prefer marketing oral contraceptive pills to churn out
considerable and constant revenues compared to one-time revenue generated through long-acting
contraceptives. Moreover, there is heavy promotion of oral pills compared to the long acting
contraceptives such as IUD, and implant. This has kept the consumers away from the real benefits of
long acting contraceptives over the oral pills. This is the reason that oral pills dominate the U.S.
contraceptive drugs and devices market. The oral pills market is projected to experience the entry of
generics with patent expirations nearing in the forecast period.
Oral pills resulting in volatility in the U.S. contraceptive drugs and devices market
Private companies have high interest in selling contraceptive pills as they generate continuous
revenues for them compared to one-time long acting contraceptive methods. Furthermore,
patent expiration is projected to lead to a barrage of generics entering into the market, further
reducing overall average cost of drugs and in turn market revenue. Global generic
pharmaceutical companies such as Teva Pharmaceuticals, Lupin Laboratories and Cipla Limited
are at pace to launch their generic versions. Emergency contraceptive pills are among the most
popular category of pills owing to extensive promotion activities to market these products.
Report includes chapters which deeply display the following deliverable about industry :
• U.S. Contraceptives Drugs And Devices Market Research Objective and Assumption
• U.S. Contraceptives Drugs And Devices Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• U.S. Contraceptives Drugs And Devices Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global U.S. Contraceptives Drugs And Devices Market, By Regions
• U.S. Contraceptives Drugs And Devices Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• U.S. Contraceptives Drugs And Devices Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• U.S. Contraceptives Drugs And Devices Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• U.S. Contraceptives Drugs And Devices Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key companies covered as a part of this study include Teva Pharmaceutical Industries
Ltd., Church & Dwight Co. Inc., Reckitt Benckiser Plc, Pfizer, Inc., Bayer AG, Mayer
Laboratories, Inc., The Female Health Company, Cooper Surgical, Inc., Allergan plc,
Cipla Limited, and Merck & Co. Inc.
Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-toanalyst/368
Detailed Segmentation:
• U.S. Contraceptives Drugs And Devices Market, By Product Type:
• Contraceptive Drugs
• Oral Contraceptive Pills
• Contraceptive Injectables
• Topical Contraceptives
• Contraceptive Devices
• Male Contraceptive Devices
• Condoms
• Female Contraceptive Devices
• Female Condoms
• Contraceptive Diaphragms
• Contraceptive Sponges
• Contraceptive Vaginal Rings
• Intrauterine Devices
• Hormonal
• Copper-T
• Subdermal Contraceptive Implants
• Company Profiles
• Teva Pharmaceutical Industries Ltd.*
• Company Overview
• Product Portfolio
• Financial Performance
• Key Strategies
• Recent Developments
• Future Plans
• Church & Dwight Co. Inc.
• Reckitt Benckiser Plc
• Pfizer, Inc.
• Bayer AG
• Mayer Laboratories, Inc.
• The Female Health Company
• Cooper Surgical, Inc.
• Allergan Plc
• Cipla Limited
• Merck & Co. Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report